Evidence map›Paper›PMID 37766265›Full record

ArticleViruses2023

Burden of HPV-Related Hospitalization in Germany from 2000 to 2021.

Georgios Tampakoudis, Olympia E Anastasiou

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Georgios TampakoudisMaternal-Fetal Medicine and Obstetrics Saint Luke's Hospital, 55236 Thessaloniki, Greece.
Olympia E AnastasiouInstitute for Virology, Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0003-2178-3182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HPV has been linked to the development of precancerous and cancerous lesions. The aim of this study was to evaluate the burden of HPV-related hospitalization in Germany from 2000 to 2021 and the potential impact of the COVID-19 pandemic on it.

methodsWe performed a retrospective query using data from the German Statistical Office from 2000 to 2021, including hospital admission, inpatient mortality and hospital stay length data on cervical cancer/dysplasia, female genitourinary tract, anal, penile, head and neck cancers.

resultsThe HPV-attributable hospitalization rate per 100,000 inhabitants in Germany has decreased over time, from 89 cases in 2000 to 60 in 2021, with an average annual percent change (AAPC) of -1.93 (CI -2.08--1.79,

conclusionOur study provides a comprehensive analysis of the trends in HPV-related hospitalizations over the past two decades. The decline in hospitalization rates for cervical cancer and dysplasia suggests the potential efficacy of the HPV vaccination and screening programs.

Indexed as

COVID-19Papillomavirus InfectionsUterine Cervical NeoplasmsFemaleGermanyHospitalizationHumansHyperplasiaPandemicsRetrospective Studiesanal cancercervical cancerhead and neck cancershospitalization rateHPVinpatient mortalityoropharyngeal cancerpenile cancervaginal cancervulva cancer

Identifiers

PMID37766265
PMCPMC10538031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.